Skip to main content
Top
Published in: Rheumatology International 2/2005

01-12-2005 | Original Article

Different ELR (+) angiogenic CXC chemokine profiles in synovial fluid of patients with Behçet’s disease, familial Mediterranean fever, rheumatoid arthritis, and osteoarthritis

Authors: Hakan Erdem, Salih Pay, Muhittin Serdar, İsmail Şimşek, Ayhan Dinç, Uğur Muşabak, Aysel Pekel, Mustafa Turan

Published in: Rheumatology International | Issue 2/2005

Login to get access

Abstract

The aim of the present study was to determine synovial levels of ELR (+) CXC chemokines, known to attract mainly neutrophils to inflamed tissues by binding the neutrophil chemokine receptors CXCR1 and CXCR2 and promoting neovascularization in patients with various inflammatory disorders. The study group consisted of 14 patients with Behçet’s disease and nine with familial Mediterranean fever. Fourteen patients with rheumatoid arthritis and 16 with osteoarthritis served as controls. Synovial chemokine levels were measured by two-step sandwich enzyme-linked immunosorbent assay, and significant differences were found in the various chemokines studied. In addition to its angiogenic properties, increased synovial levels of interleukin-8 by attraction of more neutrophils to synovial fluids might also be responsible for the acute synovitis in patients with Behçet’s disease. However, the absence of chronic changes with the eventual development of pannus and erosions might result from relatively lower expression of interleukin-8 and the transient, short-lived nature of the arthritis observed in these patients.
Literature
1.
2.
go back to reference Cravens PD, Lipksy PE (2002) Dendritic cells, chemokine receptors and autoimmune inflammatory disease. Immunol Cell Biol 80:497–505CrossRefPubMed Cravens PD, Lipksy PE (2002) Dendritic cells, chemokine receptors and autoimmune inflammatory disease. Immunol Cell Biol 80:497–505CrossRefPubMed
3.
go back to reference McColl SR (2002) Chemokines and dendritic cells: a crucial alliance. Immunol Cell Biol 80:489–496CrossRefPubMed McColl SR (2002) Chemokines and dendritic cells: a crucial alliance. Immunol Cell Biol 80:489–496CrossRefPubMed
4.
go back to reference Koch AE, Polverini PJ, Kunkel SL, Harlow LA, Dipietro LA, Elner VM, Elner SG, Strieter RM (1995) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 21:447–448 Koch AE, Polverini PJ, Kunkel SL, Harlow LA, Dipietro LA, Elner VM, Elner SG, Strieter RM (1995) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 21:447–448
6.
go back to reference Belperio JA, Keane PM, Arenberg DA, Addison CL, Ehlert JA, Burdick MD, Strieter RM (2000) CXC chemokines in angiogenesis. J Leukoc Biol 68:1–8PubMed Belperio JA, Keane PM, Arenberg DA, Addison CL, Ehlert JA, Burdick MD, Strieter RM (2000) CXC chemokines in angiogenesis. J Leukoc Biol 68:1–8PubMed
7.
go back to reference Szekanecz Z, Kim J, Koch AE (2003) Chemokines and chemokine receptors in rheumatoid arthritis. Semin Immunol 15:15–21CrossRefPubMed Szekanecz Z, Kim J, Koch AE (2003) Chemokines and chemokine receptors in rheumatoid arthritis. Semin Immunol 15:15–21CrossRefPubMed
8.
go back to reference Ferrara N (2002) Role of vascular endothelial growth factor in physiologic and pathological angiogenesis: therapeutic implications. Semin Oncol 29 [Suppl 16]:10–14 Ferrara N (2002) Role of vascular endothelial growth factor in physiologic and pathological angiogenesis: therapeutic implications. Semin Oncol 29 [Suppl 16]:10–14
9.
go back to reference Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuserier N (1987) Macrophage-induced angiogenesis is mediated by tumor necrosis factor-alpha. Nature 329:630–632CrossRefPubMed Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuserier N (1987) Macrophage-induced angiogenesis is mediated by tumor necrosis factor-alpha. Nature 329:630–632CrossRefPubMed
10.
go back to reference Park CC, Morel JCM, Amin MA, Connors MA, Harlow LA, Koch AE. (2001) Evidence of IL-8 as a novel angiogenetic mediator. J Immunol 167:1644–1653PubMed Park CC, Morel JCM, Amin MA, Connors MA, Harlow LA, Koch AE. (2001) Evidence of IL-8 as a novel angiogenetic mediator. J Immunol 167:1644–1653PubMed
11.
go back to reference Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ (1995) Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 10:517–519CrossRef Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ (1995) Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 10:517–519CrossRef
12.
go back to reference Folkman J, Klagsbrun M (1987) Angiogenic factors. Science 235:442–447PubMed Folkman J, Klagsbrun M (1987) Angiogenic factors. Science 235:442–447PubMed
13.
go back to reference Szeknecz Z, Szegedi G, Koch AE (1998) Angiogenesis in rheumatoid arthritis: pathogenic and clinical significance. J Investig Med 46:27–41PubMed Szeknecz Z, Szegedi G, Koch AE (1998) Angiogenesis in rheumatoid arthritis: pathogenic and clinical significance. J Investig Med 46:27–41PubMed
14.
go back to reference Koch AE. (2000) The role of angiogenesis in rheumatoid arthritis: recent developments. Ann Rheum Dis 59 [Suppl 1]:i65–i71 Koch AE. (2000) The role of angiogenesis in rheumatoid arthritis: recent developments. Ann Rheum Dis 59 [Suppl 1]:i65–i71
15.
go back to reference Weber AJ, De Bandt M (2000) Angiogenesis: general mechanisms and implications for rheumatoid arthritis. Joint Bone Spine 67:366–383PubMed Weber AJ, De Bandt M (2000) Angiogenesis: general mechanisms and implications for rheumatoid arthritis. Joint Bone Spine 67:366–383PubMed
16.
go back to reference Bodolay E, Koch AE, Kim J, Szegedi G, Szekanecz Z (2002) Angiogenesis and chemokines in rheumatoid arthritis and other systemic inflammatory rheumatic diseases. J Cell Mol Med 6:357–376PubMed Bodolay E, Koch AE, Kim J, Szegedi G, Szekanecz Z (2002) Angiogenesis and chemokines in rheumatoid arthritis and other systemic inflammatory rheumatic diseases. J Cell Mol Med 6:357–376PubMed
17.
go back to reference Pay S, Erdem H, Serdar M, Dinç A, Şimşek İ, Turan M. (2002) Comparison of synovial MMP-1 and TIMP-1 levels in patients with various inflammatory arthritides: is there any difference between rheumatoid arthritis, Behçet’s disease and familial Mediterranean fever? Clin Rheumatol 21:511–515CrossRefPubMed Pay S, Erdem H, Serdar M, Dinç A, Şimşek İ, Turan M. (2002) Comparison of synovial MMP-1 and TIMP-1 levels in patients with various inflammatory arthritides: is there any difference between rheumatoid arthritis, Behçet’s disease and familial Mediterranean fever? Clin Rheumatol 21:511–515CrossRefPubMed
18.
go back to reference Haywood L, McWilliams DF, Pearson CI, Gill SE, Ganesan A, Wilson D, Walsh DA (2003) Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum 48:2173–2177CrossRefPubMed Haywood L, McWilliams DF, Pearson CI, Gill SE, Ganesan A, Wilson D, Walsh DA (2003) Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum 48:2173–2177CrossRefPubMed
19.
go back to reference International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080PubMed International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080PubMed
20.
go back to reference Livneh A, Langevitz P, Zemer D (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885PubMed Livneh A, Langevitz P, Zemer D (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885PubMed
21.
go back to reference Altman RD (1991) Criteria for classification of clinical osteoarthritis. J Rheumatol 18:10–12 Altman RD (1991) Criteria for classification of clinical osteoarthritis. J Rheumatol 18:10–12
22.
go back to reference Calabrese LH, Michel BA; Bloch DA. (1990) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 33:1108–1113PubMed Calabrese LH, Michel BA; Bloch DA. (1990) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 33:1108–1113PubMed
23.
go back to reference Peichl P, Ceska M, Effenberg F, Haberhauer G, Broell H, Lindley IJ (1991) Presence of NAP-1/IL-8 in synovial fluids indicates a possible pathogenic role in rheumatoid arthritis. Scand J Immunol 34:333–339PubMed Peichl P, Ceska M, Effenberg F, Haberhauer G, Broell H, Lindley IJ (1991) Presence of NAP-1/IL-8 in synovial fluids indicates a possible pathogenic role in rheumatoid arthritis. Scand J Immunol 34:333–339PubMed
24.
go back to reference Walz A, Schumutz P, Mueller C, Schnyder-Candrian S (1997) Regulation and function of the CXC chemokine ENA-78 in monocytes and its role in disease. J Leukoc Biol 62:604–611PubMed Walz A, Schumutz P, Mueller C, Schnyder-Candrian S (1997) Regulation and function of the CXC chemokine ENA-78 in monocytes and its role in disease. J Leukoc Biol 62:604–611PubMed
25.
go back to reference Koch AE, Kunkel Sl, Harlow LA, Mazarakis DD, Haines GK, Burdick MD, Pope RM, Walz A, Strieter RM (1994) Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis. J Clin Invest 94:1012–1018PubMed Koch AE, Kunkel Sl, Harlow LA, Mazarakis DD, Haines GK, Burdick MD, Pope RM, Walz A, Strieter RM (1994) Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis. J Clin Invest 94:1012–1018PubMed
26.
go back to reference Koch AE, Kunkel SL, Shah MR, Hosaka S, Halloran MM, Haines GK, Burdick MD, Pope RM, Strieter RM (1995) Growth-related gene product alpha. A chemotactic cytokine for neutrophils in rheumatoid arthritis. J Immunol 155:3660–3666PubMed Koch AE, Kunkel SL, Shah MR, Hosaka S, Halloran MM, Haines GK, Burdick MD, Pope RM, Strieter RM (1995) Growth-related gene product alpha. A chemotactic cytokine for neutrophils in rheumatoid arthritis. J Immunol 155:3660–3666PubMed
27.
go back to reference Damme JV, Wuyts A, Froyen G, Coillie EV, Struyf S, Billiau A, Proost P, Wang JM, Opdenakker G (1997) Granulocyte chemotactic protein-2 related CXC chemokines: from gene regulation to receptor usage. J Leukoc Biol 62:563–569PubMed Damme JV, Wuyts A, Froyen G, Coillie EV, Struyf S, Billiau A, Proost P, Wang JM, Opdenakker G (1997) Granulocyte chemotactic protein-2 related CXC chemokines: from gene regulation to receptor usage. J Leukoc Biol 62:563–569PubMed
28.
go back to reference Brennan FM, Zachariae COC, Chantry D, Larsen CG, Turner M, Maini RN, Marsushima K, Feldmann M (1990) Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells. Eur J Immunol 20:2141–2144PubMed Brennan FM, Zachariae COC, Chantry D, Larsen CG, Turner M, Maini RN, Marsushima K, Feldmann M (1990) Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells. Eur J Immunol 20:2141–2144PubMed
29.
go back to reference Buckley CD (2003) Why do leukocytes accumulate within chronically inflamed joints? Rheumatology 42:1433–1444CrossRefPubMed Buckley CD (2003) Why do leukocytes accumulate within chronically inflamed joints? Rheumatology 42:1433–1444CrossRefPubMed
30.
go back to reference Walsh DA, Pearson C (2001) Angiogenesis in the pathogenesis of inflammatory joint and lung diseases. Arthritis Res 3:147–153CrossRefPubMed Walsh DA, Pearson C (2001) Angiogenesis in the pathogenesis of inflammatory joint and lung diseases. Arthritis Res 3:147–153CrossRefPubMed
31.
go back to reference Paleolog EM (2002) Angiogenesis in rheumatoid arthritis. Arhritis Res 4 [Suppl 3]:81–90 Paleolog EM (2002) Angiogenesis in rheumatoid arthritis. Arhritis Res 4 [Suppl 3]:81–90
32.
go back to reference Schlaak JF, Pfers I, Meyer Zum Buschenfelde KH, Marker-Hermann E (1996) Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies. Clin Exp Rheumatol 14:155–162PubMed Schlaak JF, Pfers I, Meyer Zum Buschenfelde KH, Marker-Hermann E (1996) Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies. Clin Exp Rheumatol 14:155–162PubMed
33.
go back to reference Partsch G, Steiner G, Leeb BF, Dunky A, Broll H, Smollen JS (1997) Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid. J Rheumatol 24:518–523PubMed Partsch G, Steiner G, Leeb BF, Dunky A, Broll H, Smollen JS (1997) Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid. J Rheumatol 24:518–523PubMed
34.
go back to reference Kaneko S, Satoh T, Chiba J, Ju C, Inoue K, Kagawa J (2000) Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis. Cytokines Cell Mol Ther 6:71–79CrossRefPubMed Kaneko S, Satoh T, Chiba J, Ju C, Inoue K, Kagawa J (2000) Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis. Cytokines Cell Mol Ther 6:71–79CrossRefPubMed
35.
go back to reference Pulsatelli L, Dolzani P, Piacentini A, Silvestri T, Ruggeri R, Gualtieri G, Meliconi R, Facchini A (1999) Chemokine production by human chondrocytes. J Rheumatol 26:1992–2001PubMed Pulsatelli L, Dolzani P, Piacentini A, Silvestri T, Ruggeri R, Gualtieri G, Meliconi R, Facchini A (1999) Chemokine production by human chondrocytes. J Rheumatol 26:1992–2001PubMed
36.
go back to reference Bertazzolo N, Punzi L, Stefani MP, Cesaro G, Pianon M, Finco B, Todesco S (1994) Interrelationships between interleukin (IL)-1, IL-6 and IL-8 in synovial fluid of various arthropathies. Agents Actions 41:90–92PubMed Bertazzolo N, Punzi L, Stefani MP, Cesaro G, Pianon M, Finco B, Todesco S (1994) Interrelationships between interleukin (IL)-1, IL-6 and IL-8 in synovial fluid of various arthropathies. Agents Actions 41:90–92PubMed
37.
go back to reference Ertenli I, Kiraz S, Calguneri M, Celik I, Erman M, Haznedaroglu IC, Kirazli S (2001) Synovial fluid cytokine levels in Behçet’s disease. Clin Exp Rheumatol 19 [Suppl 24]:37–41 Ertenli I, Kiraz S, Calguneri M, Celik I, Erman M, Haznedaroglu IC, Kirazli S (2001) Synovial fluid cytokine levels in Behçet’s disease. Clin Exp Rheumatol 19 [Suppl 24]:37–41
38.
go back to reference Verburgh CA, Hart MH, Aarden LA, Swaak AJ (1993) Interleukin-8 (IL-8) in synovial fluid of rheumatoid and nonrheumatoid joint effusions. Clin Rheumatol 12:494–499PubMed Verburgh CA, Hart MH, Aarden LA, Swaak AJ (1993) Interleukin-8 (IL-8) in synovial fluid of rheumatoid and nonrheumatoid joint effusions. Clin Rheumatol 12:494–499PubMed
Metadata
Title
Different ELR (+) angiogenic CXC chemokine profiles in synovial fluid of patients with Behçet’s disease, familial Mediterranean fever, rheumatoid arthritis, and osteoarthritis
Authors
Hakan Erdem
Salih Pay
Muhittin Serdar
İsmail Şimşek
Ayhan Dinç
Uğur Muşabak
Aysel Pekel
Mustafa Turan
Publication date
01-12-2005
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 2/2005
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-004-0524-3

Other articles of this Issue 2/2005

Rheumatology International 2/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.